Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Eshini Anne-Merie Panditharatna, Ph.D.

Concepts (87)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Brain Stem Neoplasms620191901.080 Why?
Glioma9202131100.950 Why?
Epigenomics220207680.530 Why?
Histones6202125660.390 Why?
Brain Neoplasms5202185900.330 Why?
Epigenesis, Genetic1202033370.310 Why?
Mutation62020288480.210 Why?
Autopsy420209750.210 Why?
Genomics1201549210.190 Why?
Body Fluids120193210.170 Why?
Pons220162510.170 Why?
Gene Expression Regulation, Neoplastic4202088950.140 Why?
Polymerase Chain Reaction2202164640.130 Why?
Molecular Diagnostic Techniques120185960.130 Why?
Genetic Predisposition to Disease12015170710.120 Why?
Leukemia1202014490.120 Why?
Neoplasms12020195380.110 Why?
Niacinamide120134230.110 Why?
Genetic Heterogeneity120157600.110 Why?
Molecular Targeted Therapy2202028840.100 Why?
Sequence Analysis, RNA1201919300.100 Why?
Specimen Handling120156930.100 Why?
Child102021713610.100 Why?
Chromatin1202025030.090 Why?
Telomere120147970.090 Why?
Neuroblastoma1201311440.080 Why?
DNA Methylation1202039870.080 Why?
Indoles1201319190.070 Why?
Neoplasm Staging12018112650.060 Why?
Bone Neoplasms1201325970.050 Why?
Age Factors12018192950.050 Why?
Feasibility Studies2202148070.050 Why?
Telomerase220147460.050 Why?
Limit of Detection120192500.050 Why?
Reference Standards120218910.040 Why?
Humans1220216866630.040 Why?
Antineoplastic Combined Chemotherapy Protocols12019111150.040 Why?
Child, Preschool52020411590.040 Why?
Class Ia Phosphatidylinositol 3-Kinase12016730.040 Why?
Activin Receptors, Type I120161420.040 Why?
Mice, Inbred NOD1202019740.040 Why?
Cerebrum120161310.040 Why?
Neoplasm Recurrence, Local1201386100.040 Why?
Mice, SCID1202029130.030 Why?
Phosphoprotein Phosphatases120163570.030 Why?
Magnetic Resonance Imaging22018331860.030 Why?
Stereotaxic Techniques120165310.030 Why?
Principal Component Analysis120169870.030 Why?
Tumor Cells, Cultured1202068350.030 Why?
Gene Expression Profiling2202096610.030 Why?
Xenograft Model Antitumor Assays1202038810.030 Why?
Brain Stem120168320.030 Why?
Young Adult42020560520.030 Why?
Antineoplastic Agents12013138980.030 Why?
Oligonucleotides120136050.030 Why?
Astrocytoma120147770.020 Why?
RNA, Messenger22016134690.020 Why?
Area Under Curve1201317380.020 Why?
Adolescent42020849570.020 Why?
Tissue and Organ Procurement120158170.020 Why?
Leukocytes, Mononuclear1201316260.020 Why?
Prognosis22021289230.020 Why?
Phosphatidylinositol 3-Kinases1201628330.020 Why?
Pilot Projects1201977910.020 Why?
Infant22020339180.020 Why?
Tumor Suppressor Protein p531201629120.020 Why?
Sensitivity and Specificity12021150750.020 Why?
Drug Administration Schedule1201351820.020 Why?
Neoplasm Metastasis1201653910.020 Why?
RNA1201424930.020 Why?
Biopsy1201668490.020 Why?
Female620203754590.020 Why?
Reproducibility of Results12021193080.020 Why?
Disease-Free Survival1201471950.020 Why?
Kaplan-Meier Estimate1201469700.010 Why?
Male520203524650.010 Why?
Brain Mapping1201664210.010 Why?
Disease Progression12016132040.010 Why?
Image Processing, Computer-Assisted1201689260.010 Why?
Phenotype12016160910.010 Why?
Treatment Outcome22016609910.010 Why?
Drug Resistance, Neoplasm1201352650.010 Why?
Adult220202114000.010 Why?
Time Factors12016422710.010 Why?
Signal Transduction12016243510.010 Why?
Animals120201708490.010 Why?
Retrospective Studies12014673200.000 Why?
Panditharatna's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (87)
Explore
_
Co-Authors (3)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.